RenaissanceRe price target raised to $290 from $280 at Morgan Stanley

Morgan Stanley analyst Bob Huang raised the firm’s price target on RenaissanceRe (RNR) to $290 from $280 and keeps an Overweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026, the analyst tells investors.